Funding Opportunities

NIH Funding Opportunities

Notice of Change to the Research Areas of Focus for PAR-17-267 "Modeling of Infectious Disease Agent Study Research Projects (R01)"
Notice NOT-AI-18-039 from the NIH Guide for Grants and Contracts
Mon, 09 Jul 2018 11:26:52 EST

NIAID OMNIBUS BROAD AGENCY ANNOUNCEMENT No. HHS-NIH-NIAID-BAA2018: Soliciting Proposals for Antimicrobial Products, Novel Vaccines and Technologies Against Category A, B, and C Agents, and Universal Influenza Vaccines
Notice NOT-AI-18-048 from the NIH Guide for Grants and Contracts
Thu, 12 Jul 2018 10:53:54 EST

Notice of NCI Participation in PA-18-343, "Academic Research Enhancement Award (R15 Clinical Trial Required)"
Notice NOT-CA-18-094 from the NIH Guide for Grants and Contracts
Mon, 09 Jul 2018 11:39:52 EST

Notice of Change of Requirements for RFA-DA-19-002, "Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
Notice NOT-DA-18-016 from the NIH Guide for Grants and Contracts
Mon, 09 Jul 2018 11:13:13 EST

Notice of Intent to Publish a Funding Opportunity Announcement for The National Drug Abuse Treatment Clinical Trials Network (UG1) Clinical Trial Optional
Notice NOT-DA-18-024 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 01:19:53 EST

Notice of NIDCD and NEI Interest in Supporting Research on Usher Syndrome
Notice NOT-DC-18-007 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 12:43:48 EST

Notice of Clarification of Eligible Individuals [Program Director(s)/Principal Investigator(s)] for RFA-DK-18-009, Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)
Notice NOT-DK-18-018 from the NIH Guide for Grants and Contracts
Mon, 09 Jul 2018 12:42:16 EST

Notice of NICHD Participation in PAR-17-471 "Detection of HIV for Self-Testing (R61/R33)"
Notice NOT-HD-18-008 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 12:37:23 EST

Notice of Change to Due Date and Foreign Institutions Eligibility for Applications to RFA-HD-19-018: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
Notice NOT-HD-18-014 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 01:55:29 EST

Notice of NHGRI Interest in Receiving Letters Requesting Permission to Submit Applications to Support Biennial ELSI Research Conferences (U13)
Notice NOT-HG-18-009 from the NIH Guide for Grants and Contracts
Thu, 05 Jul 2018 09:22:04 EST

NHLBI Announces Participation in PA-17-444 "Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)"
Notice NOT-HL-18-621 from the NIH Guide for Grants and Contracts
Mon, 09 Jul 2018 10:40:35 EST

Notice of NHLBI Participation in PA-18-723 "Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)"
Notice NOT-HL-18-640 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 02:02:14 EST

Notice of NHLBI Participation in PA-18-722 "Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)"
Notice NOT-HL-18-641 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 01:28:46 EST

Notice of Information for HIV research priorities at the National Heart, Lung, and Blood Institute
Notice NOT-HL-18-642 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 01:08:28 EST

Notice of Intent to Publish Funding Opportunity Announcement to Promote Screening and Management of Unhealthy Alcohol Use in Primary Care (R18)
Notice NOT-HS-18-011 from the NIH Guide for Grants and Contracts
Tue, 10 Jul 2018 12:17:40 EST

Notice of Change to Instructions for NOT-OD-18-195 "Notice of Availability of Administrative Supplements for NIH Grants Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives"
Notice NOT-OD-18-203 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 01:45:53 EST

Notice of Change to Instructions for NOT-OD-18-194 "Notice of Availability of Administrative Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
Notice NOT-OD-18-204 from the NIH Guide for Grants and Contracts
Wed, 11 Jul 2018 01:38:51 EST

Notice Announcing FAQs Page for PAR-18-307 "Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)" and PAR-18-324 "Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)"
Notice NOT-OD-18-208 from the NIH Guide for Grants and Contracts
Tue, 10 Jul 2018 09:23:17 EST

Request for Information (RFI): Challenges and Opportunities in Understanding Nuclear Organization in Space and Time (4D Nucleome)
Notice NOT-RM-18-017 from the NIH Guide for Grants and Contracts
Mon, 09 Jul 2018 11:30:36 EST

Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-18-036 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to continue a Leadership Group (LG) for a Clinical Research Network on Antibacterial Resistance (AR), which was initiated to develop, implement, and manage a clinical research program to address key clinical research questions in AR. The LG is a cohesive program dependent on the highly integrated and complimentary activities of the four centers that comprise the network: Scientific Leadership Center (SLC), Clinical Operations Center (COC), Laboratory Center (LC) and Statistics and Data Management Center (SDMC).
Mon, 09 Jul 2018 11:03:48 EST

Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DC-19-002 from the NIH Guide for Grants and Contracts. The NIDCD Temporal Bone Registry is a national research resource for human auditory and vestibular research. Its fundamental purpose is to coordinate information about specimens of the human ear and to recruit potential temporal bone donors. The Registry coordinates specimen collection, information recording and data management of specimens, and provides public information, including an up-to-date website about human ear specimens for research. It is not a simple database or tissue bank for human ear specimens. Applications are encouraged that will enhance, promote, and support critical research on the human middle and inner ear that cannot be done in living humans. Use of temporal bone specimens also provides an opportunity for translation from critical animal models to human models for auditory and vestibular research. This initiative will support the Registry by cooperative agreement, to: continue to develop and maintain a growing database for access to detailed information about the location, condition, and other bioinformatics data about new and archival human temporal bone tissues around the country that are available as resources for auditory and vestibular research; communicate with scientific and clinical researchers to disseminate information about the resources available; maintain a well-organized nationwide network of on-call experts for timely post-mortem harvesting of temporal bone tissues; develop and implement a strategy for receipt of harvested tissue by nearby temporal bone laboratories; develop new methods or techniques for donor recruitment and post-mortem tissue procurement; communicate with pledges for tissue donation combined with relevant medical histories that will allow linking functional disorders to morphological, biochemical and genetic pathologies; provide education/outreach to the scientific community and to the public about temporal bone donations.
Thu, 05 Jul 2018 11:42:16 EST

Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-19-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to develop physiologically relevant models of amelogenesis that are robust and validated so that they can advance studies of healthy and diseased human conditions involving teeth. The objectives of this FOA are two-fold: 1) generate new and improved models that closely mimic physiological enamel development and maturation to empower studies of amelogenesis, and 2) validate those models to ensure they are robust and accurately reflect human physiology and pathology. These tandem objectives will be accomplished with an Exploratory/Developmental Phased Award Cooperative Agreement (UG3/UH3) mechanism, where the UG3 developmental phase is initiated and carried out through a milestone-driven process which will then be assessed to determine if advancement to the UH3 phase providing subsequent support to further advance the UG3 outcomes will be granted . It is expected this FOA will enhance the capability of resources to serve biomedical research and accelerate understanding of multiscale processes of enamel formation to inform strategies to mitigate diseases affecting enamel and associated structures.
Wed, 11 Jul 2018 02:19:41 EST

Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional)
Funding Opportunity PA-18-849 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age and prevent illness and disability in later years.
Thu, 05 Jul 2018 09:59:49 EST

Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)
Funding Opportunity PA-18-850 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age and prevent illness and disability in later years.
Thu, 05 Jul 2018 09:59:46 EST

NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional)
Funding Opportunity PA-18-851 from the NIH Guide for Grants and Contracts. The purpose of this administrative supplement is to facilitate translational research partnerships between junior researchers with quantitative backgrounds (in engineering or computational or physical sciences) and junior clinician-scientists from active CTSA institutions (PAR-15-304, PAR-18-464). The supplement will support the quantitative researcher, the NIBIB Translational Research Scholar, contingent upon his/her collaborating with a clinician-scientist KL2 scholar, the "partnering clinician-scientist". The partnering clinician-scientist will be supported independently of this supplement through the parent KL2 award throughout the duration of the proposed supplement. Both team members will be selected by the KL2 PI. The KL2 PI will assist the NIBIB Translational Research Scholar and the partnering clinician-scientist in developing a translational research project aligned with NIBIBs research mission under the guidance of their identified basic and clinical/translational science mentors. Based on this project, the KL2 PI will submit a supplement request under this FOA.
Thu, 05 Jul 2018 10:40:19 EST

Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-853 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support research to elucidate the chemical features of non-native molecules that cross the blood-testis and/or blood-epidydimal barriers.
Tue, 10 Jul 2018 11:37:44 EST

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-854 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes in an effort to prevent or reduce obesity. This FOA is intended to support research where opportunities for empirical study are, by their very nature, only available through expedited review and funding. All applications to this FOA must demonstrate that the evaluation of an obesity related policy and /or program offers an uncommon and scientifically compelling research opportunity that will only be available if the research is initiated with minimum delay. For these reasons, applications in response to this time-sensitive FOA are not eligible for re-submission. It is intended that eligible applications selected for funding will be awarded within 4 months of the application due date. However, administrative requirements and other unforeseen circumstances may delay issuance dates beyond that timeline.
Thu, 12 Jul 2018 10:38:57 EST